Samalin Investment Counsel’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $287K | Sell |
6,198
-1,010
| -14% | -$46.8K | 0.11% | 253 |
|
|
2025
Q1 | $440K | Sell |
7,208
-217
| -3% | -$13.2K | 0.18% | 176 |
|
|
2024
Q4 | $420K | Sell |
7,425
-1,231
| -14% | -$69.6K | 0.18% | 184 |
|
|
2024
Q3 | $448K | Sell |
8,656
-1,792
| -17% | -$92.7K | 0.19% | 174 |
|
|
2024
Q2 | $434K | Sell |
10,448
-1,337
| -11% | -$55.5K | 0.2% | 168 |
|
|
2024
Q1 | $639K | Buy |
11,785
+870
| +8% | +$47.2K | 0.3% | 101 |
|
|
2023
Q4 | $560K | Sell |
10,915
-541
| -5% | -$27.8K | 0.28% | 112 |
|
|
2023
Q3 | $665K | Sell |
11,456
-3,254
| -22% | -$189K | 0.38% | 79 |
|
|
2023
Q2 | $941K | Sell |
14,710
-602
| -4% | -$38.5K | 0.51% | 46 |
|
|
2023
Q1 | $1.06M | Sell |
15,312
-1,670
| -10% | -$116K | 0.64% | 39 |
|
|
2022
Q4 | $1.22M | Sell |
16,982
-362
| -2% | -$26K | 0.77% | 34 |
|
|
2022
Q3 | $1.23M | Buy |
17,344
+86
| +0.5% | +$6.11K | 0.9% | 30 |
|
|
2022
Q2 | $1.33M | Sell |
17,258
-3,239
| -16% | -$249K | 0.94% | 29 |
|
|
2022
Q1 | $1.5M | Buy |
20,497
+657
| +3% | +$48K | 0.91% | 24 |
|
|
2021
Q4 | $1.24M | Sell |
19,840
-4,055
| -17% | -$253K | 0.74% | 31 |
|
|
2021
Q3 | $1.41M | Buy |
23,895
+1,000
| +4% | +$59.2K | 0.92% | 21 |
|
|
2021
Q2 | $1.53M | Sell |
22,895
-7,764
| -25% | -$519K | 0.99% | 19 |
|
|
2021
Q1 | $1.94M | Sell |
30,659
-316
| -1% | -$19.9K | 1.3% | 13 |
|
|
2020
Q4 | $1.92M | Buy |
30,975
+1,382
| +5% | +$85.7K | 1.44% | 12 |
|
|
2020
Q3 | $1.78M | Buy |
29,593
+1,448
| +5% | +$87.3K | 1.59% | 10 |
|
|
2020
Q2 | $1.65M | Buy |
28,145
+14,871
| +112% | +$874K | 1.73% | 10 |
|
|
2020
Q1 | $739K | Sell |
13,274
-86
| -0.6% | -$4.79K | 0.99% | 27 |
|
|
2019
Q4 | $857K | Buy |
+13,360
| New | +$857K | 0.72% | 31 |
|